Applicability of the FISH test for bladder cancer
Ward-Smith, P.; Miller, B.; Caughron, M.
Urologic Nursing 30(4): 218
2010
ISSN/ISBN: 1053-816X PMID: 20949805 Document Number: 642050
Fluorescence in situ hybridization (FISH) analysis is an FDA-approved, urine-based marker that assists in diagnosis and surveillance of invasive urothelial cancer. This article provides an overview and case study demonstrating the clinical use of this analysis. As a systematic review of non-randomized and randomized clinical trials, this article provides Level I evidence.
Document emailed within 1 workday
Related Documents
Iori, F.; De Matteis, A.; Frioni, D.; De Dominicis, C.; Leonardo, C.; Vahedi, M.; Laurenti, C. 1999: Role of urinary cytology in the study of bladder cancer. Comparison with the BTA test Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 71(5): 279-282Yamauchi, T.; Okada, K.; Yoshida, O.; Kawai, T. 1986: Chemosensitivity test for bladder cancer in a nude-mice experimental system Hinyokika Kiyo. Acta Urologica Japonica 32(12): 1949-1958
Zippe, C.; Pandrangi, L.; Potts, J.M.; Kursh, E.; Novick, A.; Agarwal, A. 1999: NMP22: a sensitive, cost-effective test in patients at risk for bladder cancer Anticancer Research 19(4a): 2621-2623
Grünberger, J.; Haub, G. 1970: Factor analysis study of alcoholics. (The applicability of a certain psychological test method) Wiener Medizinische Wochenschrift 120(14): 243-246
Montalvo Toro, J.; Rodríguez, J. 2000: Development of the Test of Attitudes and Knowledge concerning Old Age: a pilot project on its applicability in Puerto Rico Boletin de la Asociacion Medica de Puerto Rico 92(1-3): 45-49
Higuchi, S.; Kawamura, S.; Yasuda, Y. 1979: Studies on the isolation and characterization of theilerial antigens: particularly on the applicability to passive hemagglutination test Kitasato Archives of Experimental Medicine 52(1-4): 1-14
Gregersen, B.; Mommsen, S.; Svanholm, H. 1999: Bladder tumor antigen test versus urinary cytology in patients with bladder tumors Ugeskrift for Laeger 161(14): 2071-2073
Del Zingaro, M.; Bruno, R.; Nunzi, E.; Porena, M.; Mearini, L. 2016: First and second transurethral resections in intermediate-high risk bladder cancer: impact of the surgeon's volume on the recurrence and progression of primary bladder cancer Minerva Urologica e Nefrologica 68(2): 194-203
Deniz, A.; Mischke, R.; Nolte, I. 1995: Applicability of activated partial thromboplastin time (APTT) as a screening test of milk to medium deficiencies of coagulation factors in cats Deutsche Tierärztliche Wochenschrift 102(5): 206-208
Konno, M.; Ishii, H.; Doki, Y.; Mori, M. 2015: Cancer Reprogramming and its Clinical Applicability Nihon Geka Gakkai Zasshi 116(6): 357-359
Mommsen, S.; Jakobsen, A.; Sell, A. 1989: Quality of life in patients with advanced bladder cancer. a randomized study comparing cystectomy and irradiation--the Danish Bladder Cancer Study Group (DAVECA protocol 8201) Scandinavian Journal of Urology and Nephrology. Supplementum 125: 115-120
Lieselotte Lübbe; Nowack, R.; May, M.; Ullmann, K.; Gunia, S.; Kaufmann, O.; Hakenberg, O.; Muche, J.; Hoschke, B. 2004: FISH - A New Noninvasive Method for the Diagnosis of Urinary Bladder Carcinomas Clinical Laboratory 50(7-8): 395-402
Aihara, R.; Sato, K.; Sasaki, K.; Hosaka, Y.; Narita, T. 1985: Pre and postoperative nursing of patients with bladder cancer. Nursing of a patient in the terminal stage of bladder cancer with poor prognosis Nursing Technique 31(11): 1492-1497
Miyazaki, J. 2018: IIi .Current Status of Bladder Preservation Therapy for Muscle Invasive Bladder Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(1): 33-37
Ericson, K.J.; Murthy, P.B.; Bryk, D.J.; Ramkumar, R.R.; Broughman, J.R.; Khanna, A.; Mian, O.Y.; Campbell, S.C. 2019: Bladder-sparing treatment of nonmetastatic muscle-invasive bladder cancer Clinical Advances in Hematology and Oncology: H&o 17(12): 697-707
Held, J.; Volpe, H. 1991: Bladder preserving combined modality therapy for invasive bladder cancer Oncology Nursing Forum 18(1): 49-57
Sekita, N.; Egoshi, K.; Hamano, S.; Matsuzaki, O. 2006: Ileovesical fistula caused by bladder cancer with bladder stone Hinyokika Kiyo. Acta Urologica Japonica 52(10): 793-796
Punga-Maole, M.L.; Hubert, J.; Mangin, P. 1995: Bladder retraction, a complication of chemoprophylaxis of superficial bladder cancer using intravesical mitomycin C. Apropos of a case and review of the literature Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 5(4): 580-585
Flanagan, M.J.; Ekbal, S.; Coogan, P.S.; Kalin, G.; Hass, G.M. 1975: Tryptophan urinary bladder absorption and bladder cancer Investigative Urology 13(1): 17-19
Fitzpatrick, R.; Paterson, N.R.; Belanger, E.C.; McCurdy, A.; Watterson, J. 2017: Primary amyloidosis of the bladder; a mimicker of bladder cancer Canadian Journal of Urology 24(3): 8868-8870